drugset / Trial / NCT01201057

Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

NCT01201057

Phase 2 Completed 132 enrolled Starpharma Pty Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy of SPL7013 Gel in the treatment of bacterial vaginosis.

Timeline

Start
2010-08
Primary completion
2011-03
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject SPL7013 Other / unclassified 0.5 % Other
Subject SPL7013 Other / unclassified 1 % Other
Subject SPL7013 Other / unclassified 3 % Other

Indications